357 related articles for article (PubMed ID: 21875439)
1. An immunologic portrait of cancer.
Ascierto ML; De Giorgi V; Liu Q; Bedognetti D; Spivey TL; Murtas D; Uccellini L; Ayotte BD; Stroncek DF; Chouchane L; Manjili MH; Wang E; Marincola FM
J Transl Med; 2011 Aug; 9():146. PubMed ID: 21875439
[TBL] [Abstract][Full Text] [Related]
2. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.
Galon J; Angell HK; Bedognetti D; Marincola FM
Immunity; 2013 Jul; 39(1):11-26. PubMed ID: 23890060
[TBL] [Abstract][Full Text] [Related]
3. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Bedognetti D; Ceccarelli M; Galluzzi L; Lu R; Palucka K; Samayoa J; Spranger S; Warren S; Wong KK; Ziv E; Chowell D; Coussens LM; De Carvalho DD; DeNardo DG; Galon J; Kaufman HL; Kirchhoff T; Lotze MT; Luke JJ; Minn AJ; Politi K; Shultz LD; Simon R; Thórsson V; Weidhaas JB; Ascierto ML; Ascierto PA; Barnes JM; Barsan V; Bommareddy PK; Bot A; Church SE; Ciliberto G; De Maria A; Draganov D; Ho WS; McGee HM; Monette A; Murphy JF; Nisticò P; Park W; Patel M; Quigley M; Radvanyi L; Raftopoulos H; Rudqvist NP; Snyder A; Sweis RF; Valpione S; Zappasodi R; Butterfield LH; Disis ML; Fox BA; Cesano A; Marincola FM;
J Immunother Cancer; 2019 May; 7(1):131. PubMed ID: 31113486
[TBL] [Abstract][Full Text] [Related]
4. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
[TBL] [Abstract][Full Text] [Related]
5. Toward integrative cancer immunotherapy: targeting the tumor microenvironment.
Emens LA; Silverstein SC; Khleif S; Marincola FM; Galon J
J Transl Med; 2012 Apr; 10():70. PubMed ID: 22490302
[TBL] [Abstract][Full Text] [Related]
6. Correlate tumor mutation burden with immune signatures in human cancers.
Wang X; Li M
BMC Immunol; 2019 Jan; 20(1):4. PubMed ID: 30634925
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
Finn OJ
Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
[TBL] [Abstract][Full Text] [Related]
9. Disentangling the relationship between tumor genetic programs and immune responsiveness.
Bedognetti D; Hendrickx W; Ceccarelli M; Miller LD; Seliger B
Curr Opin Immunol; 2016 Apr; 39():150-8. PubMed ID: 26967649
[TBL] [Abstract][Full Text] [Related]
10. A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.
Turan T; Kongpachith S; Halliwill K; Roelands J; Hendrickx W; Marincola FM; Hudson TJ; Jacob HJ; Bedognetti D; Samayoa J; Ceccarelli M
Br J Cancer; 2021 Feb; 124(4):760-769. PubMed ID: 33139798
[TBL] [Abstract][Full Text] [Related]
11. The immunologic aspects of poxvirus oncolytic therapy.
Worschech A; Haddad D; Stroncek DF; Wang E; Marincola FM; Szalay AA
Cancer Immunol Immunother; 2009 Sep; 58(9):1355-62. PubMed ID: 19266198
[TBL] [Abstract][Full Text] [Related]
12. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
Mylvaganam G; Yanez AG; Maus M; Walker BD
Front Immunol; 2019; 10():2109. PubMed ID: 31552045
[TBL] [Abstract][Full Text] [Related]
13. The immunologic constant of rejection.
Wang E; Worschech A; Marincola FM
Trends Immunol; 2008 Jun; 29(6):256-62. PubMed ID: 18457994
[TBL] [Abstract][Full Text] [Related]
14. Live imaging the earliest host innate immune response to preneoplastic cells using a zebrafish inducible KalTA4-ER
Laux DW; Kelly L; Bravo IR; Ramezani T; Feng Y
Methods Cell Biol; 2017; 138():137-150. PubMed ID: 28129841
[TBL] [Abstract][Full Text] [Related]
15. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
16. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
Wen J; Mao X; Cheng Q; Liu Z; Liu F
Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
[TBL] [Abstract][Full Text] [Related]
18. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
19. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
